Male hypogonadism is a condition in which men have low levels of the male hormone testosterone. Testosterone is produced in the testes and is necessary for the development of male features, such as voice deepening, face & pubic hair development, and growth of penis and testes throughout puberty. Brain produces gonadotrophin-releasing hormone, which stimulates the pituitary gland to generate luteinizing hormone and follicle stimulating hormone (gonadotrophins). Testes then stimulate and produce testosterone by gonadotrophins. Low testosterone levels are caused by testicular diseases, affecting the hypothalamus or pituitary gland. Men of any age suffer with this disease and the symptoms vary depending on the initial detection of disease in relation to puberty.
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
- Allergan plc
- Pfizer Inc.
- Bayer AG
- Eli Lilly and Company Ltd.
- Endo International plc.
- Merck & Co., Inc.
- Ferring
- Finox Biotec
- Teva Pharmaceutical Industries Ltd.
- Perrigo Company plc
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/1874
๐๐๐ ๐
๐๐๐๐๐๐๐ ๐๐
๐๐๐ ๐๐๐๐๐
โข Depending on therapy, the testosterone replacement therapy segment was highest contributor to the market in 2020, whereas gonadotropin and gonadotropin releasing hormone therapy segment is anticipated to grow at the highest CAGR during the forecast period.
โข According to drug delivery, the topical segment was highest contributor to the market in 2020, whereas transdermal patches segment is anticipated to grow at the highest CAGR during the forecast period.
โข As per the type, the pituitary disorder segment was highest contributor to the market in 2020 and is anticipated to grow at the highest CAGR during the forecast period.
โข Region-wise, North America generated the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/1874
The global male hypogonadism market is segmented on the basis of therapy, drug delivery, and type. Depending on therapy, it is divided into testosterone replacement therapy and gonadotropin & gonadotropin-releasing hormones therapy. The gonadotropin-releasing hormones therapy segment is segmented into luteinizing hormone (LH), follicle-stimulating hormone (FSH), human chorionic gonadotropin (HCG), and gonadotropin-releasing hormone (GNRH). According to drug delivery, it is fragmented into topical gels, injectable, transdermal patches, and others. As per the type, it is categorized into klinefelters syndrome, kallmann syndrome, pituitary disorders, and others. Region wise, it is categorized into North America, Europe, Asia Pacific, and LAMEA.
By therapy, testosterone replacement therapy segment held largest male hypogonadism market share in 2020, owing to increase in number of patients suffering from diabetes and blood pressure. However, gonadotropins and gonadotropins releasing hormones therapy is anticipated to be the fastest growing segment during the forecast period.
Depending on drug delivery, topical gels segment dominated the market as the highest revenue generating segment, which is attributed to rise in temporary replacement of testosterone however, injectable segment is anticipated to flourish during the forecast period.
As per the type, pituitary disorders segment dominated the market and is expected to be dominant during the forecast period.
Region wise, North America dominated the market, owing to increase in awareness campaigns and technological advancement in field of male health therapeutics.
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of โMarket Research Reportsโ and โBusiness Intelligence Solutions.โ AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com